![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
IJ Reynolds
Department of Pharmacology, University of Pittsburgh, Pennsylvania.
This study investigated the interaction between the polyamines spermine and spermidine and the N-methyl-D-aspartate (NMDA) receptor by using (+)-[3H]-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-im ine maleate ([3H]MK801) binding to well washed rat brain membranes. The actions of arcaine, agmatine, diethylenetriamine and 1,8-octanediamine as polyamine antagonists were compared to use as tools in this study. Arcaine was found to be the antagonist of choice due to its greater potency. Several divalent cations, including Ba++, Ca++ and Sr++, but not Zn++, decreased the apparent potency of arcaine. These cations enhance [3H]MK801 binding in a similar fashion to spermidine and spermine suggesting that they may share a common site and mechanism of action. Moreover, arcaine competitively reduced the enhancement of [3H]MK801 binding produced by Sr++ did not alter the inhibition produced by higher concentrations of this cation, a phenomenon that also occurs with spermidine. The distinct arcaine sensitivity of the two separate phases of the concentration-response curves of both spermidine and Sr++ suggests two separate mechanisms underlying the action of spermidine-like drugs on the NMDA receptor. Further investigation of the increase in [3H]MK801 binding produced by spermidine revealed that spermidine increased the equilibrium affinity of this ligand by 2-fold without significantly altering the density of binding sites. In contrast, polyamine induced increases in the dissociation of [3H]MK801 required higher polyamine concentrations than necessary to increase ligand binding and were relatively insensitive to arcaine. These findings suggest that polyamines do not activate or promote the activation of the NMDA receptor, but instead enhance [3H]MK801 binding by allosterically increasing ligand affinity.
This article has been cited by other articles:
|
|
 |
|
  J. Satriano, M. Isome, R. A. Casero Jr., S. C. Thomson, and R. C. Blantz Polyamine transport system mediates agmatine transport in mammalian cells Am J Physiol Cell Physiol, July 1, 2001; 281(1): C329 - C334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Greenberg, J. George, Y. Wollman, I. Shapira, S. Laniado, and G. Keren The Effect of Agmatine Administration on Ischemic-Reperfused Isolated Rat Heart Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2001; 6(1): 37 - 45. [Abstract] [PDF]
|
|
|
|
 |
|
 T. A. Sharma and I. J. Reynolds Characterization of the Effects of Polyamines on [125I]MK-801 Binding to Recombinant N-Methyl-D-Aspartate Receptors J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1041 - 1047. [Abstract] [Full Text]
|
|
|
|
|
|
Z. Shao, I. R. Mellor, M. J. Brierley, J. Harris, and P. N. R. Usherwood Potentiation and Inhibition of Nicotinic Acetylcholine Receptors by Spermine in the TE671 Human Muscle Cell Line J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1269 - 1276. [Abstract] [Full Text]
|
|
|
|
|
|
A. Mukhin, E. S. Kovaleva, and E. D. London Two Affinity States of N-Methyl-D-Aspartate Recognition Sites: Modulation by Cations J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 945 - 954. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. Skjarbak, K. J. Nielsen, R. J. Lewis, P. Alewood, and D. J. Craik Determination of the Solution Structures of Conantokin-G and Conantokin-T by CD and NMR Spectroscopy J. Biol. Chem., January 24, 1997; 272(4): 2291 - 2299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Traynelis, M Hartley, and S. Heinemann Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines Science, May 12, 1995; 268(5212): 873 - 876. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
